348
Views
2
CrossRef citations to date
0
Altmetric
Articles

An assessment of the stability of MDMA, methamphetamine and THC in oral fluid

, , &
Pages 397-410 | Received 03 Oct 2013, Accepted 17 Dec 2013, Published online: 05 Feb 2014

References

  • Speedy T, Baldwin D, Jowett G, Gallina M, Jehanli A. Development and validation of the Cozart DDS oral fluid collection device. Forensic Sci Int. 2007;170:117–120.10.1016/j.forsciint.2007.03.038
  • Blencowe T, Pehrsson A, Lillsunde P. Analytical evaluation of oral fluid screening devices and preceding selection procedures [Internet]. DRUID: 2010 [ cited 2013 Jan 2]. Available from: www.druid-project.eu/nn...3.../Deliverable_3_2_2.pdf.
  • Ventura M, Pichini S, Ventura R, Leal S, Zuccaro P, Pacifici R, de la Torre R. Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes. Ther Drug Monit. 2009;31(2):277–280.10.1097/FTD.0b013e318198670b
  • Strano-Rossi S, Anzillotti L, Castrignano E, Felli M, Serpelloni G, Mollica R, Chiarotti M. UHPLC-ESI-MS/MS method for direct analysis of drugs of abuse in oral fluid for DUID assessment. Anal Bioanal Chem. 2011;401:609–624.10.1007/s00216-011-5108-y
  • Vanstechelman S, Isalberti C, van der Linden T, Pil K, Legrand S, Verstraete A. Analytical evaluation of four on-site oral fluid drug testing devices. J Anal Toxicol. 2012;36:136–140.10.1093/jat/bkr016
  • Cone EJ, Huestis MA. Interpretation of Oral Fluid Tests for Drugs of Abuse. Ann NY Acad Sci. 2007;1098:51–103.10.1196/annals.1384.037
  • Verstraete A. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit. 2004;26(2):200–205.10.1097/00007691-200404000-00020
  • Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, de la Torre R. Oral fluid testing: promises and pitfalls. Clin Chem. 2011;57(6):805–810.10.1373/clinchem.2010.152124
  • Victoria TPo (1986 (Version 113). Version incorporating amendments as at 13 May 2009). Road Safety Act. Melbourne.
  • Drummer OH, Gerostamoulos D, Chu M, Swann P, Boorman M, Cairns I. Drugs in oral fluid in randomly selected drivers. Forensic Sci Int. 2007;170(2–3):105–110.10.1016/j.forsciint.2007.03.028
  • De Giovanni N, Fucci N, Chiarotti M, Scarlata S. Cozart Rapiscan system: our experience with saliva tests. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;773(1):1–6.10.1016/S0378-4347(01)00522-9
  • Kintz P, Brunet B, Muller J, Serra W, Villain M, Cirimele V, Mura P. Evaluation of the Cozart DDSV test for cannabis in oral fluid. Ther Drug Monit. 2009;31(1):131–134.10.1097/FTD.0b013e3181947916
  • Beyer J, Chu M, Gerostamoulos D, Drummer O (2009). Detection and validated quantification of 31 drugs of abuse in oral fluid. Paper presented at the 47th Annual Meeting of The International Association of Forensic Toxicologists (TIAFT), Geneva, 23-27 Aug, 2009.
  • Chu M, Gerostamoulos D, Beyer J, Rodda L, Boorman M, Drummer OH. The incidence of drugs of impairment in oral fluid from random roadside testing. Forensic Sci Int. 2012;215(1–3):28–31.10.1016/j.forsciint.2011.05.012
  • Molnar A, Lewis J, Doble P, Hansen G, Prolov T, Fu S. A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry. Forensic Sci Int. 2012;215(1–3):92–96.10.1016/j.forsciint.2011.01.045
  • Committee CH-039, Detection of drugs in oral fluid. Australian Standard: Procedures for specimen collection and the detection and quantitation of drugs in oral fluid. AS4769:2006, vol 5.17. Standards Australia, Sydney.
  • Molnar A, Lewis J, Fu S. Recovery of spiked Delta9-tetrahydrocannabinol in oral fluid from polypropylene containers. Forensic Sci Int. 2013;227(1–3):69–73.10.1016/j.forsciint.2012.11.006
  • Marcotte H, Lavoie MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev. 1998;62(1):71–109.
  • Moore C, Vincent M, Rana S, Coulter C, Agrawal A, Soares J. Stability of Delta(9)-tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device. Forensic Sci Int. 2006;164(2–3):126–130.10.1016/j.forsciint.2005.12.011
  • Lee D, Milman G, Schwope DM, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin Chem. 2012;58(7):1101–1109.10.1373/clinchem.2012.184929
  • Wille SM, Di Fazio V, Ramirez-Fernandez Mdel M, Kummer N, Samyn N. Driving Under the Influence of Cannabis: Pitfalls, Validation, and Quality Control of a UPLC-MS/MS Method for the Quantification of Tetrahydrocannabinol in Oral Fluid Collected With StatSure, Quantisal, or Certus Collector. Ther Drug Monit. 2013;35(1):101–111.
  • Wille SM, Di Fazio V. Driving Under the Influence of Cannabis. Drug Monit. 2013;35(1):101–111.10.1097/FTD.0b013e318278dbe4
  • Concheiro M, de Castro A, Quintela O, Lopez-Rivadulla M, Cruz A. Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection. Forensic Sci Int. 2005;150(2–3):221–226.10.1016/j.forsciint.2004.12.041

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.